These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5368600)

  • 21. Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD.
    Celli BR; Tashkin DP; Rennard SI; McElhattan J; Martin UJ
    Respir Med; 2011 Aug; 105(8):1176-88. PubMed ID: 21531124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of papaverine and arpenal on the pulmonary rheogram in bronchial asthma and chronic non-specific pulmonary diseases].
    Arsent'ev FV
    Ter Arkh; 1968 Nov; 40(11):17-21. PubMed ID: 4393712
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [FEV1 after three years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease].
    Zagdańska R; Grzelewska-Rzymowska I
    Pneumonol Alergol Pol; 2005; 73(2):142-7. PubMed ID: 16756143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative assessment of the efficiency of three new bronchodilators (salbutamol, terbutaline, Th 1165 a) in the management of patients with chronic obstructive lung disease.
    Manicatide MA; Racoveanu CL; Nicolaescu VV; Teculescu DB
    Rev Roum Med Intern; 1973; 10(1):49-56. PubMed ID: 4571833
    [No Abstract]   [Full Text] [Related]  

  • 27. Post-bronchodilator spirometry reference values in adults and implications for disease management.
    Johannessen A; Lehmann S; Omenaas ER; Eide GE; Bakke PS; Gulsvik A
    Am J Respir Crit Care Med; 2006 Jun; 173(12):1316-25. PubMed ID: 16556696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Categorisation of ventilatory pattern of response to bronchodilator therapy in airflow limitation.
    Meenakshi S
    J Assoc Physicians India; 1995 Mar; 43(3):179-81. PubMed ID: 11256903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
    Walker PP; Calverley PM
    COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease.
    Hay JG; Stone P; Carter J; Church S; Eyre-Brook A; Pearson MG; Woodcock AA; Calverley PM
    Eur Respir J; 1992 Jun; 5(6):659-64. PubMed ID: 1628722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis.
    Assayag D; Vittinghoff E; Ryerson CJ; Cocconcelli E; Tonelli R; Hu X; Elicker BM; Golden JA; Jones KD; King TE; Koth LL; Lee JS; Ley B; Shum AK; Wolters PJ; Ryu JH; Collard HR
    Respir Med; 2015 Aug; 109(8):1058-62. PubMed ID: 26140806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced vital capacity in chronic obstructive pulmonary disease. Index of coexisting restrictive lung disease?
    Goyal P; Wadhwani B; Sobol BJ
    N Y State J Med; 1969 Sep; 69(17):2329-31. PubMed ID: 5258258
    [No Abstract]   [Full Text] [Related]  

  • 33. When should a reversibility test be performed on patients with early stages of asthma and normal spirometry?
    Sposato B; Mariotta S; Ricci A
    J Asthma; 2008 Aug; 45(6):479-83. PubMed ID: 18612900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seven measures of ventilatory lung function. Population values and a comparison of their ability to discriminate between persons with and without chronic respiratory symptoms and disease, Tecumseh, Michigan.
    Higgins MW; Keller JB
    Am Rev Respir Dis; 1973 Aug; 108(2):258-72. PubMed ID: 4720691
    [No Abstract]   [Full Text] [Related]  

  • 35. The status of bronchodilator treatment.
    Clark TJ
    Postgrad Med J; 1971 Mar; 47():Suppl:50-3. PubMed ID: 5572517
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease.
    Svedmyr N; Malmberg R; Thiringer G
    Scand J Respir Dis; 1972; 53(5):302-13. PubMed ID: 4404808
    [No Abstract]   [Full Text] [Related]  

  • 37. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
    Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
    J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory and circulatory investigations in obstructive and restrictive lung disease.
    Gabriel SK
    Acta Med Scand Suppl; 1972; 546():1-91. PubMed ID: 4518919
    [No Abstract]   [Full Text] [Related]  

  • 39. The response to bronchodilator in asthmatic subjects: a comparison of various measures of flow rate.
    Sobol BJ; Baskette P; Dwyer K; Emirgil C
    Ann Allergy; 1975 Mar; 34(3):141-4. PubMed ID: 1124855
    [No Abstract]   [Full Text] [Related]  

  • 40. Increasing hypoxia in chronic lung disease following administration of a bronchodilator.
    Chapman TT; Hughes DT
    J Ir Med Assoc; 1966 Dec; 59(354):184-9. PubMed ID: 5980955
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.